Valuation (67%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 16.15 | N/A |
| PEG Ratio (TTM) | 2.44 | N/A |
| P/S Ratio (TTM) | 3.14 | N/A |
| P/B Ratio (TTM) | 1.36 | N/A |
| P/FCF Ratio (TTM) | -13.25 | N/A |
| Price to 5YR AVG Earnings Ratio | 18.86 | N/A |
| Price to 5YR AVG FCF Ratio | 12.40 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.83% | N/A |
| ROE (TTM) | 8.61% | N/A |
| Net Profit Margin (TTM) | 19.70% | N/A |
| ROIC 5YR AVG | -10.57% | N/A |
Growth (42%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 109.30% | 2.68% | 2.30% |
| Revenue | 1.57% | 1.20% | 2.80% |
| Net Income | 115.87% | -2.02% | -1.98% |
| Cash Flow | -26.46% | 1,668.62% | 1,075.20% |
Health (61%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 8.48 | N/A |
| Quick Ratio (TTM) | 8.48 | N/A |
| D/E Ratio (TTM) | 0.81 | N/A |
| Interest Coverage (TTM) | 0.28 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.96 | N/A |
| LTL to 5YR AVG FCF | 6.98 | N/A |
| Shares Outstanding Growth 5YR AVG | -5.37% | N/A |